HB 2576

  • Texas House Bill
  • 86th Legislature (2019)
  • Introduced in House May 10, 2019
  • Passed House May 07, 2019
  • Senate
  • Governor

Relating to prescribing and dispensing certain controlled substances to patients diagnosed with sickle cell disease.

Votes


Actions


May 10, 2019

Senate

Referred to Health & Human Services

  • Referral-Committee
Health & Human Services

Senate

Read first time

May 07, 2019

House

Reported engrossed

House

Record vote

Senate

Received from the House

House

Passed

House

Read 3rd time

May 06, 2019

House

Passed to engrossment

House

Read 2nd time

May 02, 2019

House

Placed on General State Calendar

Apr 30, 2019

House

Considered in Calendars

Apr 16, 2019

House

Committee report sent to Calendars

House

Committee report distributed

Apr 15, 2019

House

Comte report filed with Committee Coordinator

Apr 08, 2019

House

Considered in formal meeting

House

Reported favorably as substituted

House

Committee substitute considered in committee

Apr 03, 2019

House

Committee substitute considered in committee

House

Left pending in committee

House

Testimony taken/registration(s) recorded in committee

House

Considered in public hearing

Mar 11, 2019

House

Read first time

House

Referred to Public Health

  • Referral-Committee
Public Health

Feb 27, 2019

House

Filed

Bill Text

Bill Text Versions Format
Introduced PDF HTML

Related Documents

Document Format
Witness List (House Committee Report) HTML
Fiscal Note (Introduced) HTML
Analysis (House Committee Report) HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Texas Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.

  • ftp://ftp.legis.state.tx.us/bills/86R/billhistory/house_bills/HB02500_HB02599/HB 2576.xml